Regen BioPharma, Inc. Share Price Other OTC
Equities
RGBP
US75886M1027
Biotechnology & Medical Research
Sales 2022 | 236K 18.85M | Sales 2023 | 237K 18.94M | Capitalization | 6.33M 507M |
---|---|---|---|---|---|
Net income 2022 | 2M 160M | Net income 2023 | 1M 80.05M | EV / Sales 2022 | 144 x |
Net Debt 2022 | 1.22M 97.89M | Net Debt 2023 | 635K 50.85M | EV / Sales 2023 | 29.4 x |
P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.14% |
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 23/04/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 23/04/12 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |